Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Puerto Rico Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20075
20086
20092
20103
20111
20121
20143
20152
20161
20172
20181
20202
20212
20222
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated4
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company19
Hoffmann-La Roche5
GlaxoSmithKline3
Novartis Pharmaceuticals2
Pfizer2
Amgen1
AstraZeneca1
Boehringer Ingelheim1
Carmot Therapeutics, Inc.1
Elcelyx Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 243
Obesity6
Diabetes Mellitus4
Overweight3
Diabetic Nephropathies2
Hyperglycemia2
Hypertension2
Non-alcoholic Fatty Liver Disease2
Renal Insufficiency, Chronic2
Albuminuria1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.